Literature DB >> 7674551

The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas.

J C Kim1, S C Tseng.   

Abstract

Human amniotic membrane isolated from the placenta contained basement membrane components such as type IV collagen, laminin, and 6 and 4 integrins, all of which remained detectable while preserved in glycerin for one week. One month after the n-heptanol removal of the total corneal epithelium and the limbal lamellar keratectomy, all rabbit eyes carried features of limbal deficiency, including conjunctival epithelial ingrowth, vascularization and chronic inflammation. Ten control eyes then received a total keratectomy, and 13 experimental eyes received an additional amniotic membrane transplantation. Three-month follow-ups revealed that all control corneas were revascularized to the center with granuloma and retained a conjunctival phenotype. In contrast, in the experimental groups, 5 corneas became clear with either minimal or no vascularization; the rest had either mild peripheral (5) or total (3) vascularization and more cloudy stroma. Using monoclonal antibodies for epithelial markers and matrix components, we concluded that the success correlated with the return of a cornea-like epithelial phenotype and the preservation of the amniotic membrane, whereas the failure maintained a conjunctival epithelial phenotype and the amniotic membrane was either partially degraded or covered by host fibrovascular stroma. Measures taken to facilitate the former might prove this procedure clinically useful for ocular surface reconstruction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674551     DOI: 10.3341/kjo.1995.9.1.32

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  30 in total

1.  Amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  D F Anderson; P Ellies; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

2.  [Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency].

Authors:  S L Scholz; H Thomasen; K Hestermann; D Dekowski; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

3.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

4.  Inhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane.

Authors:  Elizabeth Shay; Hua He; Shunsuke Sakurai; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-01       Impact factor: 4.799

5.  Ultrastructural analysis of in vivo expanded corneal epithelium on amniotic membrane.

Authors:  Hyo Shin Ha; Kye Yong Song; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

6.  Surgical treatment of necrotic scleral calcification using combined conjunctival autografting and an amniotic membrane inlay filling technique.

Authors:  B-H Kim
Journal:  Eye (Lond)       Date:  2011-08-26       Impact factor: 3.775

7.  Comparison of the therapeutic effects of extracts from Spirulina platensis and amnion membrane on inflammation-associated corneal neovascularization.

Authors:  Ling-Ling Yang; Qing-Jun Zhou; Yao Wang; Yan Gao; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

8.  A novel application of amniotic membrane in patients with bullous keratopathy.

Authors:  Hyeon Il Lee; Sang Woo Ha; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

9.  Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications.

Authors:  Henning Thomasen; Mikk Pauklin; Klaus-Peter Steuhl; Daniel Meller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-20       Impact factor: 3.117

Review 10.  Human amniotic membrane transplantation: Different modalities of its use in ophthalmology.

Authors:  Chintan Malhotra; Arun K Jain
Journal:  World J Transplant       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.